SpringWorks Therapeutics’ $316.25 Million Underwritten Common Stock Offering

Goodwin advised SpringWorks Therapeutics, Inc. on the offering. American precision medicine company SpringWorks Therapeutics (Nasdaq: SWTX) has closed a public offering of 10,905,171 shares of its common…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Sonia Carcano

Author: Sonia Carcano

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here